K5X-21176-50189
3 vaccinations
5 coded responses
30 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 121 / NY
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- RMH-64356-99984
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Registered in v-safe
-
2022-06-29
Dose 1 — Pfizer-BioNTech
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-01
-
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/crying, DiarrheaUnder 3 check-in
-
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-05
- 2022-07-06
- 2022-07-13
-
2022-07-27
Dose 2 — Moderna
- 2022-07-29
- 2022-07-31
- 2022-08-02
- 2022-08-03
- 2022-08-10
- 2022-08-17
- 2022-08-24
- 2022-09-02
-
2022-09-07
Survey response — day 42, dose 2, under 3MedDRA: Nasal congestion, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Head cold- stuffy and somewhat runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Survey response — 3 months, dose 2, under 3MedDRA: Ear infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Double ear infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Report sent to call center — 3 months, dose 2, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-27
Call successfulCompleted over the phone
-
2023-01-25
Survey response — 6 months, dose 2, under 3MedDRA: Ear infection, Sinusitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-25
Report sent to call center — 6 months, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-26
Call successfulCompleted over the phone
-
2023-02-02
Dose 3 — Moderna
- 2023-02-03
- 2023-02-04
-
2023-02-05
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2023-02-06
- 2023-02-07
-
2023-02-12
Survey response — day 7, dose 3, under 3MedDRA: SARS-CoV-2 test positive, Syncope — Feeling: Poor · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend schoolMedDRA releases: 2024-11
-
2023-02-16
Survey response — day 14, dose 3, under 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-02-23
- 2023-03-02
- 2023-03-11
- 2023-03-16
- 2023-05-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-29 | Pfizer-BioNTech | No |
| 2 | 2022-07-27 | Moderna | No |
| 3 | 2023-02-02 | Moderna | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 2
Free text
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Head cold- stuffy and somewhat runny nose
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Double ear infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Syncope | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release